Company profile for Nobelpharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nobelpharma, founded in 2003 with a mission to "Contribute to medical care by developing, manufacturing, and delivering essential medicines that other companies do not pursue," has achieved remarkable success in obtaining marketing approvals for new drugs within just over a decade. Our track record in securing approvals is comparable to that of large pharmaceutical companies, and we take great pride in providing these drugs to...
Nobelpharma, founded in 2003 with a mission to "Contribute to medical care by developing, manufacturing, and delivering essential medicines that other companies do not pursue," has achieved remarkable success in obtaining marketing approvals for new drugs within just over a decade. Our track record in securing approvals is comparable to that of large pharmaceutical companies, and we take great pride in providing these drugs to patients. Our success stems from our unique corporate philosophy, which underpins every aspect of our operations.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
Shinkawa, Chuo-ku, Tokyo 104-0033
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/08/2977520/0/en/Y-mAbs-Reports-Third-Quarter-2024-Financial-Results-and-Recent-Corporate-Developments.html

GLOBENEWSWIRE
08 Nov 2024

https://www.globenewswire.com/news-release/2024/11/04/2973962/0/en/Y-mAbs-and-Nobelpharma-Announce-Exclusive-License-and-Distribution-Agreement-for-DANYELZA-naxitamab-gqgk-in-Japan.html

GLOBENEWSWIRE
04 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty